Rafael Holdings is a holding company with interests in clinical and early-stage pharmaceutical companies, through an investment in Cornerstone Pharmaceuticals, Inc. (Cornerstone), a cancer metabolism-based therapeutics company, a majority equity interest in LipoMedix Pharmaceuticals Ltd., a clinical stage pharmaceutical company, the Barer Institute Inc., a wholly-owned preclinical cancer metabolism research operation, an investment in Cyclo Therapeutics, Inc., a clinical-stage biotechnology company, and Rafael Medical Devices, Inc., a wholly-owned orthopedic-focused medical device company developing instruments to advance minimally invasive surgeries. We show 22 historical shares outstanding datapoints in our coverage of RFL's shares outstanding history.
Understanding the changing numbers of RFL shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like RFL versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching RFL by allowing them to research RFL shares outstanding history
as well as any other stock in our coverage universe. |
Free RFL Email Alerts:
Video: Shares Outstanding Importance
